ENDRA LIFE SCIENCES INC. Cash, Period Increase (Decrease)
ENDRA LIFE SCIENCES INC. (NDRA) reported Cash, Period Increase (Decrease) of $4.57 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2021-11-15
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for the quarter ending 2021-09-30 was -$2.25M, a 173.90% decline year-over-year.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for the quarter ending 2021-06-30 was -$2.80M.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for the quarter ending 2021-03-31 was $9.62M.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for the quarter ending 2020-12-31 was $3.43M, a 11.92% decline year-over-year.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for fiscal 2020 was $1.05M.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for fiscal 2019 was -$297.17K, a 134.18% decline from fiscal 2018.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for fiscal 2018 was $869.50K, a 84.07% decline from fiscal 2017.
- ENDRA LIFE SCIENCES INC. cash, period increase (decrease) for fiscal 2017 was $5.46M, a 4236.92% increase from fiscal 2016.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month | Cash, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | -$2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$5.05M derived: sum of 2 quarters · filed 2021-11-15 | $4.57M 10-Q · filed 2021-11-15 | $8.00M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2021-06-30 | -$2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $6.82M 10-Q · filed 2021-08-12 | $10.25M derived: sum of 3 quarters · filed 2021-08-12 | $13.29M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2021-03-31 | $9.62M 10-Q · filed 2021-05-17 | $13.05M derived: sum of 2 quarters · filed 2021-05-17 | $16.09M derived: sum of 3 quarters · filed 2021-11-15 | $13.74M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $6.48M derived: sum of 2 quarters · filed 2021-11-15 | $4.12M derived: sum of 3 quarters · filed 2021-11-15 | $1.05M 10-K · filed 2021-03-25 | |
| 2020-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $690.57K derived: sum of 2 quarters · filed 2021-11-15 | -$2.38M 10-Q · filed 2021-11-15 | $1.52M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$5.43M 10-Q · filed 2021-08-12 | -$1.53M derived: sum of 3 quarters · filed 2021-08-12 | -$1.52M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$3.07M 10-Q · filed 2021-05-17 | $827.43K derived: sum of 2 quarters · filed 2021-05-17 | $835.20K derived: sum of 3 quarters · filed 2021-05-17 | -$822.75K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $3.91M derived: sum of 2 quarters · filed 2021-03-25 | $2.25M derived: sum of 3 quarters · filed 2021-03-25 | -$297.17K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $7.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$1.65M derived: sum of 2 quarters · filed 2020-11-16 | -$4.20M 10-Q · filed 2020-11-16 | $1.64M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$4.20M 10-Q · filed 2020-08-14 | $1.63M derived: sum of 3 quarters · filed 2020-08-14 | $61.67K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$2.55M 10-Q · filed 2020-05-14 | $3.29M derived: sum of 2 quarters · filed 2020-05-14 | $1.72M derived: sum of 3 quarters · filed 2020-05-14 | $775.49K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $4.27M derived: sum of 2 quarters · filed 2020-03-26 | $3.32M derived: sum of 3 quarters · filed 2020-03-26 | $869.50K 10-K · filed 2020-03-26 | |
| 2018-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$2.51M derived: sum of 2 quarters · filed 2019-11-13 | -$4.96M 10-Q · filed 2019-11-13 | -$6.34M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | -$944.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$3.40M 10-Q · filed 2019-08-08 | -$4.77M derived: sum of 3 quarters · filed 2019-08-08 | -$5.32M derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | -$2.45M 10-Q · filed 2019-05-14 | -$3.83M derived: sum of 2 quarters · filed 2019-05-14 | -$4.37M derived: sum of 3 quarters · filed 2019-05-14 | $3.02M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$1.92M derived: sum of 2 quarters · filed 2019-03-11 | $5.47M derived: sum of 3 quarters · filed 2019-03-11 | $5.46M 10-K · filed 2019-03-11 | $5.46M 10-K · filed 2018-03-20 |
| 2017-09-30 | -$546.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $6.84M derived: sum of 2 quarters · filed 2018-11-05 | $6.83M 10-Q · filed 2018-11-05 | $6.90M derived: sum of 4 quarters · filed 2018-11-05 | |
| 2017-06-30 | $7.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $7.38M 10-Q · filed 2018-08-13 | $7.45M derived: sum of 3 quarters · filed 2018-08-13 | $7.02M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | -$11.27K 10-Q · filed 2018-05-15 | $58.14K derived: sum of 2 quarters · filed 2018-05-15 | -$370.44K derived: sum of 3 quarters · filed 2018-05-15 | $113.31K derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $69.41K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$359.16K derived: sum of 2 quarters · filed 2018-03-20 | $124.58K derived: sum of 3 quarters · filed 2018-03-20 | $125.83K 10-K · filed 2018-03-20 | |
| 2016-09-30 | -$428.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $55.17K derived: sum of 2 quarters · filed 2017-11-14 | $56.41K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $483.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $484.99K 10-Q · filed 2017-08-07 | |||
| 2016-03-31 | $1.24K 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |